ExCulture

ExCulture, a pharmaceutical startup, has been devoted to transforming the production method of life-saving pharmaceuticals since its founding in 2022. The company's slogan "Transforming the production method of life-saving pharmaceuticals" captures its mission well. It specializes in applying a mixed-culture fermentation bioprocess for the production of pharmaceuticals, positioning itself at the forefront of innovative production techniques within the pharmaceutical industry. The company is based in The Netherlands, a region known for its strong biotechnology sector. Notably, ExCulture secured a significant €350.00K investment in a Seed Round at 05 December 2023, with UNIIQ being the investor. This backing underscores the recognition and support ExCulture has garnered for its pioneering approach to pharmaceutical production.